Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.13 USD
Change Today +0.20 / 1.44%
Volume 887.9K
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas Davis M.D.

Chief Medical Officer and Executive Vice President,Celldex Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2014


Dr. Thomas A. Davis, also known as Tom, MD has been the Chief Medical Officer and Executive Vice President of Celldex Therapeutics, Inc. (formerly known as AVANT Immunotherapeutics Inc) since March 2008 and July 30, 2014 respectively. Dr. Davis served as Senior Vice President of Celldex Therapeutics from March 2008 to July 30, 2014. Dr.Davis served as a Vice President of Clinical Development at Celldex Therapeutics Inc., from May 2006 to March 2008. He has an extensive ...

Read Full Background

Corporate Headquarters*

Perryville III Building
Hampton, New Jersey 08827

United States

Phone: 908-200-7500
Fax: 908-454-1911

Board Members Memberships*

There is no Board Members Memberships data available.


Unknown/Other Education
Stanford University
Unknown/Other Education
Johns Hopkins University
Johns Hopkins University
Unknown/Other Education
Georgetown University
Georgetown University
Georgetown University School Of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$556,413

Stock Options*

All Other Compensation$8,749
Exercisable Options505,755
Exercisable Options Value$5,743,454
Unexercisable Options265,470
Unexercisable Options Value$1,643,288
Total Value of Options$7,386,741
Total Number of Options771,225

Total Compensation*

Total Annual Cash Compensation$565,162
Total Short Term Compensation$556,413
Other Long Term Compensation$8,749
Total Calculated Compensation$1,576,988
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLDX:US $14.13 USD +0.20


Kevin T. Conroy Chairman of The Board, Chief Executive Officer and President
Exact Sciences Corporation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
Stephen T. Isaacs Chairman, Chief Executive Officer and President
Aduro BioTech, Inc.
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLDEX THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at